GD LAND (00124) Issues Positive Profit Alert, Expects Profit Attributable to Shareholders of Not Less Than HK$240 Million for the First Three Quarters, Turning Around from a Year-on-Year Loss
GD LAND (00124) announced that the Group is expected to record unaudited profit attributable to owners of the Company of not less than HK$240 million for the nine months ended September 30, 2026, compared with an unaudited loss attributable to owners of the Company of approximately HK$16 million for the corresponding period in 2025.
GD LAND (00124) has announced that the Group is expected to record an unaudited profit attributable to owners of the Company of not less than HK$240 million for the nine months ended September 30, 2026, compared with an unaudited loss attributable to owners of the Company of approximately HK$16 million for the same period in 2025.
The main factors affecting the aforementioned expected results of the Group for the nine months ended September 30, 2026 include: affected by the latest real estate market environment, based on indications of impairment in certain property projects of the Group, the inventory impairment provisions made by the Group during the current review period decreased significantly compared with the same period in 2025;
the Group recorded a decrease in fair value losses on investment properties (net of relevant deferred tax expenses) during the current review period compared with the same period in 2025; and
the properties delivered by the Group during the current review period were mainly the Foshan Yuehai Yigui Mansion and Guangzhou Yuehai Yungang City projects; among them, the Guangzhou Yuehai Yungang City project had a relatively higher gross profit margin, and the total gross floor area delivered during the current review period decreased, leading to a decrease in property sales profits compared with the same period in 2025.
Related Articles

INSPUR DIGI ENT (00596) repurchased 100,000 shares for approximately HK$177,300 on October 16.

EDGE MEDICAL-B (02675) repurchased 152,300 shares for approximately HK$4.7309 million on October 16.

TSINGTAO BREW (00168) controlling shareholder and its persons acting in concert have cumulatively increased their shareholding in the company by 2.0422 million shares.
INSPUR DIGI ENT (00596) repurchased 100,000 shares for approximately HK$177,300 on October 16.

EDGE MEDICAL-B (02675) repurchased 152,300 shares for approximately HK$4.7309 million on October 16.

TSINGTAO BREW (00168) controlling shareholder and its persons acting in concert have cumulatively increased their shareholding in the company by 2.0422 million shares.






